Dae-Sung Kim
Direktor/Vorstandsmitglied bei Great Orient Chemical Pte Ltd.
Aktive Positionen von Dae-Sung Kim
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ID Biochem, Inc.
ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Comptroller/Controller/Auditor | - | - |
Great Orient Chemical Pte Ltd. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Dae-Sung Kim
Ehemalige bekannte Positionen von Dae-Sung Kim
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ISU ABXIS CO., LTD. | Direktor/Vorstandsmitglied | 12.11.2010 | - |
Vorstandsvorsitzender | 30.06.2014 | 24.03.2017 | |
Corporate Officer/Principal | 11.08.2011 | 30.06.2014 | |
ISU PETASYS CO., LTD. | Direktor/Vorstandsmitglied | - | - |
Corporate Officer/Principal | - | - | |
ISU CHEMICAL CO., LTD | Direktor/Vorstandsmitglied | 06.09.2010 | - |
Finanzdirektor/CFO | 06.09.2010 | - |
Ausbildung von Dae-Sung Kim
Seoul National University | Undergraduate Degree |
Statistik
International
Südkorea | 6 |
Singapur | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Sektoral
Process Industries | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ISU CHEMICAL CO., LTD | Process Industries |
ISU ABXIS CO., LTD. | Health Technology |
ISU PETASYS CO., LTD. | Electronic Technology |
Private Unternehmen | 2 |
---|---|
ID Biochem, Inc.
ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Process Industries |
Great Orient Chemical Pte Ltd. |
- Börse
- Insiders
- Dae-Sung Kim
- Erfahrung